These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The Influence of the Route of Antibiotic Administration, Methicillin Susceptibility, Vancomycin Duration and Serum Trough Concentration on Outcomes of Pediatric Staphylococcus aureus Bacteremic Osteoarticular Infection. McNeil JC, Kaplan SL, Vallejo JG. Pediatr Infect Dis J; 2017 Jun; 36(6):572-577. PubMed ID: 28027279 [Abstract] [Full Text] [Related]
3. Predictive Factors to Guide Empiric Antimicrobial Therapy of Acute Hematogenous Osteomyelitis in Children. Hoyer EA, Joseph M, Kaplan SL, Vallejo JG, McNeil JC. Pediatr Infect Dis J; 2023 Jun 01; 42(6):449-455. PubMed ID: 36795576 [Abstract] [Full Text] [Related]
4. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. Gawronski KM, Goff DA, Brown J, Khadem TM, Bauer KA. Clin Ther; 2013 Jun 01; 35(6):772-9. PubMed ID: 23795575 [Abstract] [Full Text] [Related]
6. [A multicentric study on clinical characteristics and antibiotic sensitivity in children with methicillin-resistant Staphylococcus aureus infection]. Wu X, Yu H, He LY, Wang CQ, Xu HM, Zhao RQ, Jing CM, Chen YH, Chen J, Deng JK, Shi J, Lin AW, Li L, Deng HL, Cai HJ, Chen YP, Wen ZW, Yang JH, Zhang T, Xiao FF, Cao Q, Huang WC, Hao JH, Zhang CH, Huang YY, Ji XF. Zhonghua Er Ke Za Zhi; 2020 Aug 02; 58(8):628-634. PubMed ID: 32842382 [Abstract] [Full Text] [Related]
7. Clinical characteristics and therapeutic outcomes of hematogenous vertebral osteomyelitis caused by methicillin-resistant Staphylococcus aureus. Park KH, Chong YP, Kim SH, Lee SO, Choi SH, Lee MS, Jeong JY, Woo JH, Kim YS. J Infect; 2013 Dec 02; 67(6):556-64. PubMed ID: 23916563 [Abstract] [Full Text] [Related]
8. Establishment of a new methicillin resistant Staphylococcus aureus animal model of osteomyelitis. Helbig L, Simank HG, Lorenz H, Putz C, Wölfl C, Suda AJ, Moghaddam A, Schmidmaier G, Guehring T. Int Orthop; 2014 Apr 02; 38(4):891-7. PubMed ID: 24170130 [Abstract] [Full Text] [Related]
9. Vancomycin therapy and the progression of methicillin-resistant Staphylococcus aureus vertebral osteomyelitis. Gelfand MS, Cleveland KO. South Med J; 2004 Jun 02; 97(6):593-7. PubMed ID: 15255429 [Abstract] [Full Text] [Related]
13. In vivo assessment of the antimicrobial activity of a calcium-deficient apatite vancomycin drug delivery system in a methicillin-resistant Staphylococcus aureus rabbit osteomyelitis experimental model. Amador G, Gautier H, Le Mabecque V, Miegeville AF, Potel G, Bouler JM, Weiss P, Caillon J, Jacqueline C. Antimicrob Agents Chemother; 2010 Feb 02; 54(2):950-2. PubMed ID: 19933800 [Abstract] [Full Text] [Related]
15. Vancomycin-induced reversible pancytopenia and rash in a 16-month-old boy with osteomyelitis: A case report . Leng B, Yan G, Li T, Hou N. Int J Clin Pharmacol Ther; 2020 Apr 02; 58(4):242-246. PubMed ID: 32000885 [Abstract] [Full Text] [Related]
17. Pediatric acute osteomyelitis in the postvaccine, methicillin-resistant Staphylococcus aureus era. Ratnayake K, Davis AJ, Brown L, Young TP. Am J Emerg Med; 2015 Oct 02; 33(10):1420-4. PubMed ID: 26298052 [Abstract] [Full Text] [Related]
18. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Joosten U, Joist A, Gosheger G, Liljenqvist U, Brandt B, von Eiff C. Biomaterials; 2005 Sep 02; 26(25):5251-8. PubMed ID: 15792552 [Abstract] [Full Text] [Related]